File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prolonged oral arsenic trioxide therapy and neprholithiasis [1]

TitleProlonged oral arsenic trioxide therapy and neprholithiasis [1]
Authors
Issue Date2007
PublisherInforma Healthcare. The Journal's web site is located at http://informahealthcare.com/loi/lal
Citation
Leukemia And Lymphoma, 2007, v. 48 n. 11, p. 2233-2234 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/163127
ISSN
2015 Impact Factor: 3.093
2015 SCImago Journal Rankings: 1.202
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_US
dc.contributor.authorTam, Sen_US
dc.contributor.authorFong, Ben_US
dc.contributor.authorHo, KLen_US
dc.contributor.authorTam, PCen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-05T05:27:57Z-
dc.date.available2012-09-05T05:27:57Z-
dc.date.issued2007en_US
dc.identifier.citationLeukemia And Lymphoma, 2007, v. 48 n. 11, p. 2233-2234en_US
dc.identifier.issn1042-8194en_US
dc.identifier.urihttp://hdl.handle.net/10722/163127-
dc.languageengen_US
dc.publisherInforma Healthcare. The Journal's web site is located at http://informahealthcare.com/loi/lalen_US
dc.relation.ispartofLeukemia and Lymphomaen_US
dc.rightsLeukemia and Lymphoma . Copyright © Informa Healthcare.-
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 And Overen_US
dc.subject.meshAntineoplastic Agents - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshArsenic - Urineen_US
dc.subject.meshArsenic Poisoning - Complications - Urineen_US
dc.subject.meshArsenicals - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshCase-Control Studiesen_US
dc.subject.meshDrug Administration Scheduleen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLeukemia, Promyelocytic, Acute - Drug Therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNephrolithiasis - Chemically Induceden_US
dc.subject.meshOxides - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshTime Factorsen_US
dc.titleProlonged oral arsenic trioxide therapy and neprholithiasis [1]en_US
dc.typeArticleen_US
dc.identifier.emailKwong, YL:ylkwong@hku.hken_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1080/10428190701625081en_US
dc.identifier.pmid17926176-
dc.identifier.scopuseid_2-s2.0-36049001925en_US
dc.identifier.hkuros145674-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-36049001925&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume48en_US
dc.identifier.issue11en_US
dc.identifier.spage2233en_US
dc.identifier.epage2234en_US
dc.identifier.isiWOS:000250839100023-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridAu, WY=7202383089en_US
dc.identifier.scopusauthoridTam, S=7202037323en_US
dc.identifier.scopusauthoridFong, B=16507017100en_US
dc.identifier.scopusauthoridHo, KL=35763728100en_US
dc.identifier.scopusauthoridTam, PC=7202539419en_US
dc.identifier.scopusauthoridKwong, YL=7102818954en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats